Koster Theodoor David, Dijk Marlies Van, Slebos Dirk-Jan
Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Semin Respir Crit Care Med. 2022 Aug;43(4):541-551. doi: 10.1055/s-0042-1747938. Epub 2022 May 13.
In carefully selected patients with severe chronic obstructive pulmonary disease, characterized by emphysema and hyperinflation, lung volume reduction is an option to reduce lung hyperinflation, improve lung function, quality of life, and exercise capacity. Currently, there are several bronchoscopic and surgical treatment options to achieve lung volume reduction. It is important to carefully phenotype these patients, to select the optimal treatment option, with consideration of possible adverse events or contraindications, and it is highly recommended to discuss these treatment strategies in a multidisciplinary team. The treatment with one-way endobronchial valves has been investigated most extensively and more data are available regarding the treatment of more "marginal cases," or subsequent lung volume reduction surgery. Other bronchoscopic lung volume reduction options include treatment with coils, thermal vapor ablation, and sclerosant agents. In this review, we aim to summarize the current clinical evidence on the bronchoscopic lung volume reduction therapies and important aspects regarding optimal patient selection.
在精心挑选的以肺气肿和肺过度充气为特征的重度慢性阻塞性肺疾病患者中,肺减容术是一种减少肺过度充气、改善肺功能、生活质量和运动能力的选择。目前,有几种支气管镜和手术治疗方法可实现肺减容。仔细对这些患者进行表型分析,选择最佳治疗方案,并考虑可能的不良事件或禁忌症,这很重要,强烈建议在多学科团队中讨论这些治疗策略。单向支气管内瓣膜治疗的研究最为广泛,关于更多“边缘病例”的治疗或后续肺减容手术有更多数据。其他支气管镜肺减容选择包括使用线圈、热蒸汽消融和硬化剂治疗。在本综述中,我们旨在总结支气管镜肺减容治疗的当前临床证据以及最佳患者选择的重要方面。